nivolumab - Robuta Search

https://visualping.io/pages/gt90001-nivolumab-in-metastatic-hcc-clinical-trial-alerts-4962687 GT90001+Nivolumab in Metastatic HCC Clinical Trial: Get alerts for the latest updates - Visualping See the latest updates to GT90001+Nivolumab in Metastatic HCC Clinical Trial. Subscribe for free to get alerts when changes are detected to GT90001+Nivolumab... https://www.singhealth.com.sg/medicine/nivolumab Nivolumab Medication Information Leaflet nivolumab https://visualping.io/pages/nivolumab-for-recurrent-meningioma-clinical-trial-alerts-4962954 Nivolumab for Recurrent Meningioma Clinical Trial: Get alerts for the latest updates - Visualping See the latest updates to Nivolumab for Recurrent Meningioma Clinical Trial. Subscribe for free to get alerts when changes are detected to Nivolumab for... the latest updates clinical trial https://www.nice.org.uk/guidance/TA417/chapter/1-Recommendations 1 Recommendations | Nivolumab for previously treated advanced renal cell carcinoma | Guidance | NICE Evidence-based recommendations on nivolumab (Opdivo) for previously treated advanced renal cell carcinoma in adults renal cell carcinoma https://visualping.io/pages/nivolumab-with-5-azacytidine-in-childhood-aml-clinical-trial-alerts-4960404 Nivolumab with 5-azacytidine in Childhood AML Clinical Trial: Get alerts for the latest updates -... See the latest updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial. Subscribe for free to get alerts when changes are detected to Nivolumab... https://adisinsight.springer.com/drugsafety/803335846?error=cookies_not_supported&code=4100ff92-cde5-4dfa-98c8-1f8a299807cb Ipilimumab/nivolumab - AdisInsight A 62-year-old woman developed immune-mediated reactions including metabolic acidosis, pericardial effusion and diabetic ketoacidosis during treatment with ipilimumab nivolumab adisinsight https://www.bmsstudyconnect.com/cz/en/clinical-trials/NCT03400332.html A Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced... The purpose of this study is to investigate experimental medication BMS-986253 in combination with Nivolumab or Nivolumab plus Ipilimumab in participants with... https://mesothelioma-lung-cancer.org/news/nivolumab-ipilimumab-first-line-mesothelioma-treatment-update/ Nivolumab + Ipilimumab for Mesothelioma: Updated Survival Data | Mesothelioma-Lung-Cancer.org Mar 24, 2026 - Updated CheckMate 743 data confirms nivolumab plus ipilimumab as first-line standard for unresectable mesothelioma with 18.1-month median survival. lung cancer nivolumab ipilimumab mesothelioma updated https://medischeoncologiegroningen.nl/artikelen/nivolumab-6/ Nivolumab - Medische Oncologie Groningen Feb 2, 2026 - Inclusie Gemetastaseerd of irresectabel MSI oesofagus/maagcarcinoom Exclusie Actieve auto-immuunziekte (zoals ziekte van Crohn) of eerdere bijwerkingen op... medische oncologie nivolumab groningen https://www.bmsstudyconnect.com/es/en/clinical-trials/NCT02864251.html A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Non-Small Cell... The main purpose of this study is to determine whether nivolumab + chemotherapy is effective as compared to chemotherapy in the treatment of patients with EGFR... a study https://www.journalonko.de/urologische-tumoren/nierenzellkarzinom/nivolumab-plus-ipilimumab-metastasiertes-nierenzellkarzinom-langzeit-follow-up-dauerhaftes-therapiefreies-ueberleben Nivolumab + Ipilimumab beim mRCC: 5-Jahres-Real-World-Daten May 1, 2026 - Eine Real-World-Studie belegt dauerhaftes therapiefreies Überleben bei 17% der mRCC-Patient:innen unter Nivolumab plus Ipilimumab. Lesen Sie mehr! real world nivolumab ipilimumab mrcc jahres https://ctv.veeva.com/study/a-study-in-ovarian-cancer-patients-evaluating-rucaparib-and-nivolumab-as-maintenance-treatment-follo?comeFrom=%7B%22type%22%3A%22site%22%2C%22slug%22%3A%22broome-oncology-llc-johnson-city-pa%22%7D A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment... This is a Phase 3, randomized, multinational, double-blind, dual placebo-controlled, 4-arm study evaluating rucaparib and nivolumab as maintenance treatment... https://www.universimed.com/ch/nejm/Perioperative_Nivolumab_and_Chemotherapy_in_Stage_III_NSCLC?page=25 Perioperative Nivolumab and Chemotherapy in Stage III NSCLC stage iii perioperative nivolumab chemotherapy nsclc https://www.wikicell.org/shop/kribiolisa-nivolumab-opdivo-elisa-96t-55472 KRIBIOLISA Nivolumab (OPDIVO) ELISA 96T | Anticorpo nivolumab opdivo elisa https://www.oncolink.org/treatment-binder/codes/ugini UGI - Nivolumab, Ipilimumab | OncoLink OncoLink, the Web's first cancer resource,provides comprehensive information on coping with cancer, cancer treatments, cancer research advances, continuing... ugi nivolumab ipilimumab https://adisinsight.springer.com/drugsafety/803928055?error=cookies_not_supported&code=ff0e3ffd-477f-4a55-85a6-1c1bcc007cd0 Nivolumab - AdisInsight A 77-year-old man with unresectable advanced gastric cancer with multiple hepatic and distant nodal metastases received third-line nivolumab [dose and route not nivolumab adisinsight https://urologycancersummit.org/iuc24428-85/ IUC24428-85 Real World Effectiveness of Ipilimumab plus Nivolumab in Second-Line in Patients with... Sep 1, 2025 - Real World Effectiveness of Ipilimumab plus Nivolumab in Second-Line in Patients with Metastatic Clear Cell Renal Cell Carcinoma (mccRCC) Based on Prior... https://ecancer.org/en/video/8320-checkmate-459-safety-and-efficacy-of-nivolumab-versus-sorafenib-as-a-first-line-treatment-in-advanced-hepatocellular-carcinoma CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line treatment in... Dr Thomas Yau speaks to ecancer at ESMO 2019 in Barcelona about the results from the CheckMate 459 trial, which assessed the use of nivolumab versus sorafeni https://systems.enpress-publisher.com/index.php/ti/article/view/8705/4806 A case of delayed initial response to combination ipilimumab and nivolumab in malignant pleural... Malignant pleural mesothelioma has a poor prognosis with limited therapeutic options Although numerous trials have shown that combination immunotherapy with... https://www.canceropole-est.org/la-recherche-au-sein-du-canceropole-est/annuaires/publications-scientifiques/detail/?id=44958 Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients... https://www.survivornet.com/clinical-trials/prostate-cancer/an-investigational-immunotherapy-study-of-nivolumab-in-combination-with-rucaparib-docetaxel-or-enzalutamide-in-metastatic-castration-resistant-prostate-cancer/ Prostate Cancer Clinical Trial: An Investigational Immunotherapy Study of Nivolumab in Combination... Apr 1, 2024 - Prostate Cancer - A Phase 2 Study of Nivolumab in Combination With Either Rucaparib, Docetaxel, or Enzalutamide in Men With Castration-resistant prostate cancer clinical trial https://pubmed.ncbi.nlm.nih.gov/33246931/ Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell... ClinicalTrials.gov identifier: NCT02231749. https://www.ijcrioncology.com/archive/article-full-text/100135Z10DM2024 Neurological immune-related toxicity to ipilimumab/nivolumab therapy in malignant melanoma: A... https://veri.larvol.com/associations/cldn18-2-expression_gastric-cancer_nivolumab+tj-cd4b Gastric Cancer - nivolumab + TJ-CD4B - CLDN18.2 expression - LARVOL VERI LARVOL VERI predictive biomarker evidence connecting Gastric Cancer, nivolumab + TJ-CD4B, and CLDN18.2 expression. gastric cancer nivolumab tj expression veri https://www.epistemonikos.org/en/documents/bc5cc3be57f27c0addd920ae313552eba72069ed A Phase 1/2a Study of BMS-986178 Administered Alone and in Combination with Nivolumab or Ipilimumab... https://ecancer.org/en/video/5543-azacitidine-plus-nivolumab-against-acute-myeloid-leukaemia Azacitidine plus nivolumab against acute myeloid leukaemia - ecancer Prof Daver joins ecancertv at ASH 2016 to discuss preliminary outcomes of immunochemotherapy targeting the PD-1 checkpoint in the treatment of AML. acute myeloid leukaemia azacitidine plus nivolumab https://www.bmsstudyconnect.com/ca/fr/clinical-trials/NCT03158272.html A Study of Cabiralzumab Given by Itself or With Nivolumab in Advanced Cancer or Cancer That Has... The purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, is safe and tolerable in the... https://visualping.io/pages/chemo-nivolumab-in-nsclc-clinical-trial-alerts-4963844 Chemo +/- Nivolumab in NSCLC Clinical Trial: Get alerts for the latest updates - Visualping See the latest updates to Chemo +/- Nivolumab in NSCLC Clinical Trial. Subscribe for free to get alerts when changes are detected to Chemo +/- Nivolumab in... https://www.kucancercenter.org/cancer-clinical-trials/find-trial/clinical-trial-results/nct03793166 PD-Inhibitor Nivolumab and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib with... https://www.trialx.com/clinical-trials/listings/320611/nivolumab-fluorouracil-and-interferon-alpha-2b-for-the-treatment-of-unresectable-fibrolamellar-cancer/ Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar... Clinical trial for Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma AJCC v8 |... https://www.selectscience.net/article/intralesional-nivolumab-may-be-effective-against-precancerous-oral-lesions Intralesional nivolumab shrinks precancerous oral lesions - SelectScience news Phase I trial: intralesional nivolumab shrank high-risk oral precancerous lesions, reduced surgery needs, and preserved quality of life. Read expert insights... nivolumab shrinks oral lesions selectscience https://globaloncologyacademy.org/programs/cme/emerging-and-practice-changing-directions-in-nsclc-within-the-perioperative-and-locally-advanced-settings/29137/ CheckMate 77T, LAURA trial, nivolumab, osimertinib, EGFR - Dr. Paz-Ares reviews emerging clinical data in the perioperative and locally advanced settings of NSCLC that have the potential to change practice checkmate laura trial nivolumab osimertinib https://pubmed.ncbi.nlm.nih.gov/34083421/ Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell... ClinicalTrials.gov NCT02488759; https://clinicaltrials.gov/ct2/show/NCT02488759. for patients with https://ascopost.com/news/january-2025/nivolumab-plus-avd-as-front-line-therapy-in-older-adults-with-classical-hodgkin-lymphoma/ Nivolumab Plus AVD as Front-Line Therapy in Older Adults With Classical Hodgkin Lymphoma - The ASCO... In a phase I/II trial reported in the Journal of Clinical Oncology, Torka et al evaluated the addition of nivolumab to standard doxorubicin, vinblastine, and... https://www.bmsclinicaltrials.com/at/de/clinical-trials/NCT04349267 Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With... Study of BMS-986315 alone and in combination with nivolumab or cetuximab in participants with advanced solid tumors https://www.medicalhalo.com/en/oncology/2580.html Nivolumab/ipilimumab combination chemotherapy can treat advanced non-small cell lung... For patients with advanced non-small cell lung cancer (NSCLC), the overall efficacy of nivolumab (Opdivo) and ipilimumab (Yervoy) combined with 2 cycles of... combination chemotherapy small cell nivolumab ipilimumab https://onlinepharmacy.pk/product/opdivo-nivolumab-100mg-injection/ Opdivo (Nivolumab) 100 mg/ml Injection in Pakistan Oct 29, 2024 - Opdivo (Nivolumab) 100mg injection is available in Pakistan at the price range of Rs. 70,000/-. to Rs. 85,000/-. Delivery All Across Pakistan. opdivo nivolumab mg ml injection https://www.bmsclinicaltrials.com/de/de/clinical-trials/NCT02910999 Studie zur praktischen Anwendungserfahrung mit Nivolumab in Patienten mit fortgeschrittenem NSCLC... Der Zweck dieser Studie ist die Wirksamkeit und Sicherheit von Nivolumab in Patienten mit fortgeschrittenem NSCLC, sowie die Patientenpopulation,... studie zur mit nivolumab patienten https://adisinsight.springer.com/drugsafety/803903326?error=cookies_not_supported&code=ffb6261f-08dd-4067-a710-c2c9d15b0b77 Nivolumab - AdisInsight A 20-year-old man developed diabetic ketoacidosis and insulin-dependent autoimmune diabetes mellitus during treatment with nivolumab for stage-IIIc melanoma of nivolumab adisinsight https://ctv.veeva.com/study/a-study-to-evaluate-two-dosing-regimens-of-subcutaneous-nivolumab-in-combination-with-intravenous-ip?comeFrom=%7B%22type%22%3A%22site%22%2C%22slug%22%3A%22university-general-hospital-of-larissa-oncology-clinic-clinical-trials-unit%22%7D A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous... The purpose of this study is to evaluate two dosing regimens of subcutaneous Nivolumab in combination with intravenous Ipilimumab and chemotherapy in... https://www.cancernetwork.com/view/nivolumab-plus-chemotherapy-enhances-responses-is-well-tolerated-in-hodgkin-lymphoma Nivolumab Plus Chemotherapy Enhances Responses, Is Well Tolerated in Hodgkin Lymphoma |... May 14, 2026 - Adult and pediatric oncology collaboration in assessing nivolumab in advanced Hodgkin lymphoma facilitated the phase 3 SWOG S1826 findings. nivolumab plus chemotherapy enhances responses https://notiziaok.it/ascierto-con-nivolumab-sottocute-un-vantaggio-win-win-per-sistema-e-pazienti Ascierto: "Con nivolumab sottocute un vantaggio win-win per sistema e pazienti" - NotiziaOk (Adnkronos) - "La recente approvazione della formulazione sottocutanea di nivolumab rappresenta un passo avanti significativo sia per i pazienti sia per... https://www.ispor.org/vih-articles/Volume-25--Supplemental-Issue-7S/HTA7-Cost-Effectiveness-Analysis-of-Nivolumab-Plus-Chemotherapy-Vs-Chemotherapy-in-Patients-with-Advanced-Gastric-Cancer-in-Japan HTA7 Cost-Effectiveness Analysis of Nivolumab Plus Chemotherapy Vs Chemotherapy in Patients with... cost effectiveness https://pure.fujita-hu.ac.jp/ja/publications/pharmacokinetics-pharmacodynamics-and-safety-of-nivolumab-in-pati/ Pharmacokinetics, pharmacodynamics, and safety of nivolumab in patients with sepsis-induced... in patients pharmacokinetics pharmacodynamics safety https://ecancer.org/en/video/8329-spice-analysis-of-enadenotucirev-plus-nivolumab-in-metastatic-colorectal-cancer-patients-during-the-dose-escalation-phase SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer patients during... Prof Marwan Fakih speaks to ecancer at ESMO 2019 in Barcelona about the results from the phase I SPICE study, which investigated the combination of enadenotu metastatic colorectal cancer https://www.cancernetwork.com/view/impact-of-ignyte-trial-responses-to-rp1-nivolumab-in-advanced-melanoma Impact of IGNYTE Trial Responses to RP1/Nivolumab in Advanced Melanoma | CancerNetwork May 19, 2026 - Sarah Weiss, MD, discussed key IGNYTE trial findings of RP1 and nivolumab in patients with advanced melanoma who progressed on prior anti-PD-1 therapy. https://nextstepsinderm.com/derm-topics/nivolumab-therapeutic-cheat-sheet/?q=/tag/off-label-uses/ Nivolumab Therapeutic Cheat Sheet - Next Steps in Dermatology Jun 4, 2025 - Nivolumab, a programmed death-1 (PD-1) immune checkpoint inhibitor, is a cornerstone in the evolving field of immuno-oncology. Originally developed for... cheat sheet next steps nivolumab therapeutic dermatology https://visualping.io/pages/nimotuzumab-and-nivolumab-in-advanced-lung-cancer-clinical-trial-alerts-4959617 Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial: Get alerts for the latest updates... See the latest updates to Nimotuzumab and Nivolumab in Advanced Lung Cancer Clinical Trial. Subscribe for free to get alerts when changes are detected to... https://www.researchandmarkets.com/report/nivolumab Nivolumab Market Size, Competitors & Forecast to 2030 The Nivolumab Market, valued at USD 2.17B in 2026, is projected to reach USD 3.63B by 2030, growing at a 13.8% CAGR. market size nivolumab competitors forecast https://thehcdata.com/bristol-myers-squibb-receives-european-commission-approval-for-opdivo-nivolumab-with-chemotherapy-as-neoadjuvant-treatment-of-resectable-non-small-cell-lung-cancer-at-high-risk-of-recurren/ Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) with Chemotherapy... Jun 30, 2023 - Bristol Myers Squibb (NYSE: BMY) today announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with platinum-based bristol myers squibb european commission https://medicalchannelasia.com/cancer/immune-checkpoint-inhibitors-in-oncology-nivolumab-opdivo/ Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo) - Medical Channel Asia Mar 15, 2026 - Nivolumab (Opdivo) has been approved to treat several types of cancers. Find out the summary of the clinical trials leading to its approval. immune checkpoint inhibitors oncology nivolumab opdivo medical https://www.odermatol.com/issue-in-html/2023-3-27-lichen_planus_nivolumab/ 2023.3.27.lichen_planus_nivolumab - Our Dermatology Online Oct 21, 2023 - Annular and ulcerative lichen planus induced by nivolumab therapy lichen planus nivolumab dermatology online https://peoplebeatingcancer.org/cost-effectivness-of-immunotherapy-for-metastatic-melanoma/ Cost-effectivness of Opdivo/nivolumab for melanoma- Sep 6, 2023 - Consider Evidence-based Integrative Therapies to Enhance the Efficacy of Melanoma Chemotherapy While Minimizing Toxicity for higher quality of life cost opdivo nivolumab melanoma https://visualping.io/pages/bms-986277-with-nivolumab-in-epithelial-cancers-clinical-trial-alerts-4959964 BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial: Get alerts for the latest updates -... See the latest updates to BMS-986277 with Nivolumab in Epithelial Cancers Clinical Trial. Subscribe for free to get alerts when changes are detected to... https://iv.iiarjournals.org/content/31/5/1035 Predictive Factors of Nivolumab-induced Hypothyroidism in Patients with Non-small Cell Lung Cancer... Background/Aim: Although immune checkpoint inhibitors play an important role in the therapy of lung cancer, they are associated with various immune-related... https://ogkologos.com/fda-approves-a-fixed-dose-combination-of-nivolumab-and-relatlimab-for-unresectable-or-metastatic-melanoma/ FDA Approves a Fixed-Dose Combination of Nivolumab and Relatlimab for Unresectable or Metastatic... https://researchnow.flinders.edu.au/en/publications/a-phase-ii-trial-of-nivolumab-followed-by-ipilimumab-and-nivoluma/fingerprints/?sortBy=alphabetically A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non-clear-cell renal... https://adisinsight.springer.com/drugsafety/803321756?error=cookies_not_supported&code=876eaec3-69f0-42f8-92d3-3c5980988070 Nivolumab - AdisInsight The male patient [age not stated] developed myositis, myasthenic crisis, myocarditis and renal failure following treatment with nivolumab [Opdivo] for non-small nivolumab adisinsight https://freepr.org/drug/4446/Nivolumab_vial Buy Nivolumab vial Online | Best Online Pharmacy for Nivolumab vial from Canada Buy Nivolumab vial online from the best online pharmacy for Nivolumab vial. Trusted Canadian pharmacy offering affordable prices, fast shipping, and secure... online best buy nivolumab vial pharmacy https://www.nrgoncology.org/Home/News/Post/exploring-the-addition-of-nivolumab-to-platinum-gemcitabine-for-recurrent-or-metastatic-nasopharyngeal-cancer-nrg-hn007/ Exploring the Addition of Nivolumab to Platinum-Gemcitabine for Recurrent or Metastatic... the addition https://www.opdivo.com/getting-treatment Getting Immunotherapy Treatment | OPDIVO Qvantig™ (nivolumab+hyaluronidase-nvhy) or OPDIVO®... Learn more about receiving OPDIVO® (nivolumab) or OPDIVO-based combination treatment. Access infusion information for your cancer type. Please see Indication... immunotherapy treatment getting opdivo nivolumab hyaluronidase https://visualping.io/pages/de-escalated-radiation-nivolumab-in-p16-oropharynx-cancer-clinical-trial-alerts-4958480 De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial: Get alerts for the... See the latest updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial. Subscribe for free to get alerts when changes are... https://medischeoncologiegroningen.nl/pifs/nivolumab-bij-irresectabel-of-uitgezaaid-melanoom-2/ Nivolumab bij irresectabel of uitgezaaid melanoom - Medische Oncologie Groningen May 7, 2021 - Behandelplan De behandeling wordt 1 keer per 4 weken via een infuus toegediend, soms kiest de arts ervoor om eens per 2 weken toe te dienen. Dit zal... medische oncologie nivolumab bij melanoom groningen https://avesis.hacettepe.edu.tr/yayin/07125f50-93b3-4d89-b79f-9cb9e6f1391b/development-of-de-novo-psoriasis-during-nivolumab-therapy-in-a-patient-with-small-cell-lung-cancer Development of de novo psoriasis during nivolumab therapy in a patient with small cell lung cancer... https://adisinsight.springer.com/drugsafety/803652228?error=cookies_not_supported&code=48b5131d-78c9-4ba2-8729-c3704dbf5e77 Ipilimumab/nivolumab - AdisInsight A 77-year-old man developed infiltration of lung fields, relapse of herpes labialis, diarrhoea, myocarditis and myasthenia gravis during treatment with ipilimumab nivolumab adisinsight https://www.proteogenix.science/product/nivolumab-elisa-kit/ Nivolumab ELISA Kit - ProteoGenix Mar 31, 2026 - Introduction to Nivolumab ELISA Kit Nivolumab is a monoclonal antibody that has been developed as a therapeutic target for the treatment of various types of... elisa kit nivolumab https://www.trialx.com/clinical-trials/listings/330683/consolidation-nivolumab-after-concurrent/ Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal... Clinical trial for Locally Advanced Nasopharyngeal Carcinoma , Consolidation Nivolumab After Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal... consolidation nivolumab concurrent locally advanced https://www.medicalhalo.com/en/oncology/2150.html FDA approves nivolumab/chemotherapy for neoadjuvant treatment of resectable NSCLC_ Medicalhalo The FDA has approved nivolumab plus platinum doublet chemotherapy for the neoadjuvant treatment of adult patients with resectable non-small cell lung cancer... fda nivolumab chemotherapy